EU and South Korean research organisations sign an agreement to work together on the development of a COVID-19 treatment usingLetter of Intent (Loi) • December 25th, 2023
Contract Type FiledDecember 25th, 2023Five research organisations from the EU and South Korea have signed a letter of intent (LOI) for international joint research on COVID-19 treatment. This agreement covers the exchange of clinical and nonclinical trial information related to their research on COVID-19 treatment using the repurposed Raloxifene molecule.
EU and South Korean research organisations sign an agreement to work together on the development of a COVID-19 treatment usingLetter of Intent (Loi) • May 23rd, 2023
Contract Type FiledMay 23rd, 2023Five research organisations from the EU and South Korea have signed a letter of intent (LOI) for international joint research on COVID-19 treatment. This agreement covers the exchange of clinical and nonclinical trial information related to their research on COVID-19 treatment using the repurposed Raloxifene molecule.